Search research articles
Contact Us
Filters
Showing results (21-30 of 58) with videos related to
Page
of 6
Sort By:
Progress in Brain Research
|
July 10, 2007
Rescuing neurons and glia: is inhibition of apoptosis useful?
E Kovesdi, E Czeiter, A Tamas, et al.
Journal of Molecular Neuroscience : MN
|
December 14, 2018
Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide
Tamas Atlasz, D Werling, S Song, et al.
Neurotoxicity Research
|
December 13, 2017
Alteration of the PAC1 Receptor Expression in the Basal Ganglia of MPTP-Induced Parkinsonian Macaque Monkeys
M Feher, B Gaszner, A Tamas, et al.
Transplantation Proceedings
|
September 13, 2015
Ischemia/reperfusion-induced Kidney Injury in Heterozygous PACAP-deficient Mice
E Laszlo, A Varga, K Kovacs, et al.
Regulatory Peptides
|
October 24, 2007
PAC1 receptor localization in a model nervous system: light and electron microscopic immunocytochemistry on the earthworm ventral nerve cord ganglia
L Molnár, E Pollák, A Boros, et al.
Journal of Molecular Neuroscience : MN
|
May 8, 2016
Structural and Morphometric Comparison of Lower Incisors in PACAP-Deficient and Wild-Type Mice
B Sandor, K Fintor, D Reglodi, et al.
Neuropharmacology
|
June 29, 2014
The selective PAC1 receptor agonist maxadilan inhibits neurogenic vasodilation and edema formation in the mouse skin
E Banki, Zs Hajna, A Kemeny, et al.
Neuropeptides
|
July 13, 2017
Effects of pituitary adenylate cyclase activating polypeptide on small intestinal INT 407 cells
A Illes, B Opper, D Reglodi, et al.
General and Comparative Endocrinology
|
February 9, 2007
Changes of PACAP levels in the brain show gender differences following short-term water and food deprivation
P Kiss, D Reglodi, A Tamás, et al.
Neurotoxicology
|
April 1, 2018
Protective effects of pituitary adenylate cyclase activating polypeptide against neurotoxic agents
D Reglodi, A Tamas, A Jungling, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 58) with videos related to
Sort By:
Page
of 6
Progress in Brain Research
|
July 10, 2007
Rescuing neurons and glia: is inhibition of apoptosis useful?
E Kovesdi, E Czeiter, A Tamas, et al.
Journal of Molecular Neuroscience : MN
|
December 14, 2018
Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide
Tamas Atlasz, D Werling, S Song, et al.
Neurotoxicity Research
|
December 13, 2017
Alteration of the PAC1 Receptor Expression in the Basal Ganglia of MPTP-Induced Parkinsonian Macaque Monkeys
M Feher, B Gaszner, A Tamas, et al.
Transplantation Proceedings
|
September 13, 2015
Ischemia/reperfusion-induced Kidney Injury in Heterozygous PACAP-deficient Mice
E Laszlo, A Varga, K Kovacs, et al.
Regulatory Peptides
|
October 24, 2007
PAC1 receptor localization in a model nervous system: light and electron microscopic immunocytochemistry on the earthworm ventral nerve cord ganglia
L Molnár, E Pollák, A Boros, et al.
Journal of Molecular Neuroscience : MN
|
May 8, 2016
Structural and Morphometric Comparison of Lower Incisors in PACAP-Deficient and Wild-Type Mice
B Sandor, K Fintor, D Reglodi, et al.
Neuropharmacology
|
June 29, 2014
The selective PAC1 receptor agonist maxadilan inhibits neurogenic vasodilation and edema formation in the mouse skin
E Banki, Zs Hajna, A Kemeny, et al.
Neuropeptides
|
July 13, 2017
Effects of pituitary adenylate cyclase activating polypeptide on small intestinal INT 407 cells
A Illes, B Opper, D Reglodi, et al.
General and Comparative Endocrinology
|
February 9, 2007
Changes of PACAP levels in the brain show gender differences following short-term water and food deprivation
P Kiss, D Reglodi, A Tamás, et al.
Neurotoxicology
|
April 1, 2018
Protective effects of pituitary adenylate cyclase activating polypeptide against neurotoxic agents
D Reglodi, A Tamas, A Jungling, et al.
Page
of 6